Journal article
Choosing optimal therapy for relapsed refractory multiple myeloma: A systematic review and network meta-analysis.
Abstract
e20037
Background: Several treatment options are available for relapsed refractory multiple myeloma(RRMM). However, in the absence of direct-comparative trials, it is unclear how to choose optimal therapy in RRMM. We conducted a network meta-analysis (NMA) to assess the comparative efficacy of different treatment options in RRMM. Methods: Standard electronic databases were searched for abstract and full-text publications of …
Authors
Nadeem M; Gupta S; Naqvi SAA; Bin Riaz I; Chakraborty R; Aljama MA; Husnain M
Journal
Journal of Clinical Oncology, Vol. 39, No. 15_suppl, pp. e20037–e20037
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2021
DOI
10.1200/jco.2021.39.15_suppl.e20037
ISSN
0732-183X